Effective January 1, 2018, the permanent J-code is J9022 (injection ...

TECENTRIQ Billing and Coding Guide

Sample billing codes for TECENTRIQ? (atezolizumab)

Effective January 1, 2018, the permanent J-code is J9022 (injection, atezolizumab, 10 mg).

HCPCS

J9022

Injection, atezolizumab, 10 mg

ICD-10-CM ¨C Upper Tract Urothelial

C65.1

Malignant neoplasm of the right renal pelvis

C66.1

Malignant neoplasm of the right ureter

C65.2

Malignant neoplasm of the left renal pelvis

C66.2

Malignant neoplasm of the left ureter

C65.9

Malignant neoplasm of unspecified renal pelvis

C66.9

Malignant neoplasm of unspecified ureter

ICD-10-CM ¨C Lower Tract Urothelial

C67.0

Malignant neoplasm of trigone of bladder

C67.6

Malignant neoplasm of ureteric orifice

C67.1

Malignant neoplasm of dome of bladder

C67.7

Malignant neoplasm of urachus

C67.2

Malignant neoplasm of lateral wall of bladder

C67.8

Malignant neoplasm of overlapping sites

of bladder

C67.3

Malignant neoplasm of anterior wall of bladder

C67.9

Malignant neoplasm of bladder, unspecified

C67.4

Malignant neoplasm of posterior wall of bladder

C68.0

Malignant neoplasm of the urethra

C67.5

Malignant neoplasm of bladder neck

ICD-10-CM ¨C Non-Small Cell Lung Cancer (NSCLC)

C34.00-C34.02

Malignant neoplasm of right and left main

bronchus, unspecified

C34.30-C34.32

Malignant neoplasm of bronchus and lung;

lower lobe

C34.10-C34.12

Malignant neoplasm of bronchus and lung;

upper lobe

C34.80-C34.82

Malignant neoplasm of bronchus and lung;

overlapping sites

C34.2

Malignant neoplasm of bronchus and lung;

middle lobe

C34.90-C34.92

Malignant neoplasm of bronchus and lung;

unspecified part

HCPCS=Healthcare Common Procedure Coding System.

ICD-10-CM=International Classification of Diseases, 10th Revision, Clinical Modification.

Additional codes on reverse side.

These codes are not all-inclusive; appropriate codes can vary by patient, setting of care and payer. Correct coding is the

responsibility of the provider submitting the claim for the item or service. Please check with the payer to verify codes and

special billing requirements. Genentech does not make any representation or guarantee concerning reimbursement or

coverage for any service or item.

Additional Codes

Additional Codes

10-digit 50242-917-01

NDC

11-digit 50242-0917-01

1200 mg/20 mL single-dose vial

96413

Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or

initial substance/drug

96415

Chemotherapy administration, intravenous infusion technique; each additional hour

(List separately in addition to code for primary procedure)

CPT

CPT=Current Procedural Terminology.

NDC=National Drug Code.

For more information:

Visit TECENTRIQ

Call (888) 249-4918 Monday through Friday, 6 a.m.¨C5 p.m. PT

These codes are not all-inclusive; appropriate codes can vary by patient, setting of care and payer. Correct coding is the

responsibility of the provider submitting the claim for the item or service. Please check with the payer to verify codes and

special billing requirements. Genentech does not make any representation or guarantee concerning reimbursement or

coverage for any service or item.

TECENTRIQ , its logo and the Access Solutions logo are registered trademarks of Genentech, Inc.

?

?2017 Genentech USA, Inc. So. San Francisco, CA

All rights reserved. ACS/110317/0319 11/17 Printed in USA

FPO

FSC CLEAR AREA

FSC FPO

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download